BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is a Safe and Credible Online Health Resource

  Progressive Care Inc. announced that its subsidiary, PharmCo, LLC, has received certification approval from LegitScript to provide verification that it is operating in compliance with applicable laws and regulation set forth to be a safe and credible online health resource.

  August 3, 2018

   · 

  3 min read
• Business

  Kannalife Sciences Finalizes Share Exchange Agreement with TYG Solutions Corp.

  Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, is pleased to announce the completion of a share exchange transaction with TYG Solutions Corp. (OTC: TYYG).

  August 3, 2018

   · 

  3 min read
• Business

  Catalyst Pharmaceuticals to Hold Second Quarter Financial Results and Corporate Update Conference Call and Webcast on Wednesday, August 8th, 2018

  Catalyst Pharmaceuticals, Inc. announced that it will release second quarter 2018 financial results after market close on Tuesday, August 7, 2018.

  August 3, 2018

   · 

  2 min read
• Business

  Organovo Announces Appointment of Steven G. Hughes, M.D. as Chief Medical Officer

  Organovo Holdings, Inc. announced that Steven G. Hughes has been named Chief Medical Officer. Dr. Hughes is an industry veteran who brings significant experience directing clinical development and medical affairs teams at leading biopharma companies.

  August 3, 2018

   · 

  5 min read
• Business

  Conformis Reports Second Quarter 2018 Financial Results

  Conformis, Inc. announced financial results for the second quarter ended June 30, 2018.

  August 3, 2018

   · 

  9 min read
• Business

  Globus Medical Reports Second Quarter 2018 Results

  Globus Medical, Inc. announced its financial results for the second quarter ended June 30, 2018.

  August 3, 2018

   · 

  17 min read
• Business

  Fibrocell to Host Conference Call and Webcast on Thursday, August 9, 2018 to Discuss Second Quarter 2018 Financial Results and Recent Highlights

  Fibrocell Science, Inc. will report financial results for the second quarter ended June 30, 2018 and recent operational highlights on Thursday, August 9, 2018 before the open of the U.S. financial markets.

  August 3, 2018

   · 

  1 min read
• Deals

  Breathtec to Open New Drug Development Division, Signs LOI to acquire 100% of Clinical Stage Nash Pharmaceuticals Inc.

  Breathtec Biomedical Inc. is pleased to announce that it will be opening a new drug development division and has signed a Letter of Intent (“LOI”) to acquire 100% of the shares of Nash Pharmaceuticals Inc.

  August 3, 2018

   · 

  7 min read
• Policy

  Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea

  Biomerica, Inc. (Nasdaq:BMRA) announced today that the Korean Intellectual Property Office (KIPO) has issued a Notice of Allowance for a patent application covering Biomerica’s compositions, devices and methods of IBS sensitivity testing. The patent is expected to issue before September 2018.

  August 3, 2018

   · 

  4 min read
• Business

  Integer Holdings Corporation Reports Second Quarter 2018 Results

  Completed Divestiture of Advanced Surgical and Orthopedics Product Lines for $600 million

  August 3, 2018

   · 

  29 min read